Skip to content

Drug interactions

Erdafitinib + Everolimus

Severity: Moderate

Erdafitinib and Everolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib inhibits P-gp and may increase everolimus absorption and exposure. This could heighten mTOR-related adverse effects.

What this interaction means in plain words

Erdafitinib and Everolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erdafitinib belongs to Oncology; Everolimus belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of P-glycoprotein efflux by erdafitinib, increasing everolimus bioavailability.

What to do

Monitor for everolimus toxicity and check trough concentrations in transplant patients. Consider dosing everolimus at least 6 hours before or after erdafitinib.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Everolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Everolimus?

MediHelp rates the interaction as moderate. Erdafitinib and Everolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib inhibits P-gp and may increase everolimus absorption and exposure. This could heighten mTOR-related adverse effects.

How serious is the interaction between Erdafitinib and Everolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for everolimus toxicity and check trough concentrations in transplant patients. Consider dosing everolimus at least 6 hours before or after erdafitinib.

What other medicines interact with Everolimus?

MediHelp also lists interactions of Everolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Levoketoconazole. The full list is on the Everolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in